(Q35039844)

5 August 2017

title

Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients (English)

1 reference

5 August 2017

0 references

1

Jan Lötvall

0 references

Ashley Woodcock

object named as

Ashley Woodcock

series ordinal

3

0 references

author name string

Stephen Langley

series ordinal

2

1 reference

5 August 2017

publication date

18 August 2006

1 reference

5 August 2017

1 reference

5 August 2017

volume

7

1 reference

5 August 2017

page(s)

110

1 reference

https://scigraph.springernature.com/pub.10.1186/1465-9921-7-110

5 August 2017

exact match

0 references

cites work

Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570354

Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570354

Sustained protection against distilled water provocation by a single dose of salmeterol in patients with asthma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570354

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570354

Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570354

Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570354

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570354

Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570354

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-110

Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-110

Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-110

Effects of beta-adrenoceptor agonists in human bronchial smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-110

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-110

Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-110

Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patien

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-110

Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma

21 January 2018

1 reference

12 December 2020

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group

1 reference

12 December 2020

Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma

1 reference

12 December 2020

A study of the duration of the bronchodilator effect of 12 micrograms and 24 micrograms of inhaled formoterol and 200 micrograms inhaled salbutamol in asthma

1 reference

12 December 2020

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

12 December 2020

Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma

1 reference

12 December 2020

Objective and subjective bronchodilation over 12 hours after inhaled formoterol: individual responses

1 reference

12 December 2020

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

12 December 2020

Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action

1 reference

12 December 2020

An overview of nine clinical trials of salmeterol in an asthmatic population

1 reference

12 December 2020

Onset and duration of action of single doses of formoterol inhaled via Turbuhaler

1 reference

12 December 2020

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-7-110

1 reference

Dimensions Publication ID

5 August 2017

1028949415

0 references

Fatcat ID

release_satjpmg34vbu7mbty4iudxvcti

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/satjpmg34vbu7mbty4iudxvcti

24 November 2022

mapped directly with Wikidata item

PMC publication ID

1570354

1 reference

5 August 2017

1 reference